| Company Name: |
SIGMA-RBI |
| Tel: |
800 736 3690 (Orders) |
| Email: |
|
|
| | (5alpha,6beta)-17-(cyclopropylmethyl)-4,5-epoxy-morphinan-3,6,14-triol hydrate Basic information |
| Product Name: | (5alpha,6beta)-17-(cyclopropylmethyl)-4,5-epoxy-morphinan-3,6,14-triol hydrate | | Synonyms: | 6BETA-NALTREXOL HYDRATE;(5α,6β)-17-(Cyclopropylmethyl)-4,5-epoxy-morphinan-3,6,14-triol hydrate;6β-Naltrexol hydrate;(5alpha,6beta)-17-(cyclopropylmethyl)-4,5-epoxy-morphinan-3,6,14-triol hydrate | | CAS: | | | MF: | C20H27NO5 | | MW: | 361.43 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File |  |
| | (5alpha,6beta)-17-(cyclopropylmethyl)-4,5-epoxy-morphinan-3,6,14-triol hydrate Chemical Properties |
| storage temp. | 2-8°C | | solubility | DMSO: ~12 mg/mL | | form | powder | | color | white |
| | (5alpha,6beta)-17-(cyclopropylmethyl)-4,5-epoxy-morphinan-3,6,14-triol hydrate Usage And Synthesis |
| Biochem/physiol Actions | Neutral antagonist of the μ-opioid receptor. A reduction of withdrawal effects associated with neutral μ-opioid receptor antagonists may offer advantages in treating opioid overdose and addiction. |
| | (5alpha,6beta)-17-(cyclopropylmethyl)-4,5-epoxy-morphinan-3,6,14-triol hydrate Preparation Products And Raw materials |
|